AbeXXa Biologics – Re-Imagining Cancer Immunotherapy for the Many
AbeXXa Biologics – Re-Imagining Cancer Immunotherapy for the Many
Search
Patients with a rare and aggressive form of liposarcoma need treatment advances
Patients with a rare and aggressive form of liposarcoma need treatment advances
How to Apply
To apply for the program, please complete one of the following application forms and follow the directions on the application form submission
Experience our culture during your interview process
Discover if our company is the right fit for you.
Contact Us
Contact Us
PAP Resources
PAP Resources
Cyltezo® (adalimumab-adbm): First Interchangeable Biosimilar | BI US
Read more about how the FDA have approved CYLTEZO as the first interchangeable biosimilar with Humira®, supported by data from BI’s Phase III clinical trial.
Work life balance
It is important that employees have a balance between professional and personal lives, so we offer various leave options and flexible working schedules.
Empowering Patients
Empowering Patients
Livestock
Livestock
Online application
Online application | FAQ
Mental Health
Mental Health
The Role of Endocrinologists and PCPs in Diagnosing Chronic Kidney Disease
Mohamed Eid shares his perspective on the role endocrinologists and primary care professionals play in diagnosing chronic kidney disease.
Outside the lab…inside the family
We are a manufacturing and a research company too. Outside of the lab, we have engineers, legal teams, logistics managers, QA/QC teams and more.
Discovery Research Global Post-Doc Program
Discovery Research Global Post-Doc Program
Why today’s depression trials demand smart new approaches
Why today’s depression trials demand smart new approaches
Targeting HER2 in cancer
Our cancer researchers share insights into the discovery of our investigational HER2-selective tyrosine kinase inhibitor.
Media Overview
Media Overview
Corporate Compliance Program
Corporate Compliance Program
Our Stories
Our Stories
See our Locations
We offer career development opportunities in over 170 locations across the world. Explore some of our featured locations.
FIBRONEER™ trials for IPF, other progressive fibrosing ILDs
Donald Zoz, M.D., Director and Senior Clinical Program Leader for Pulmonary Fibrosis, discusses the FIBRONEER™ global clinical program
Human Health
Human Health
Boehringer’s unique approach to innovation
Boehringer’s unique approach to driving patient-centric innovation
Disentangling Fibrosis: Finding ways to fix ‘repair gone wrong’
Disentangling Fibrosis: Finding ways to fix ‘repair gone wrong’